Seq_ID,Species,Phylogenetic lineage,Predicted drug resistance,Rifampicin,Isoniazid,Pyrazinamide,Ethambutol,Moxifloxacin,Amikacin,Cycloserine,Ethionamide,Kanamycin,Streptomycin,Capreomycin,Para-aminosalicylic acid,Clofazimine,Delamanid,Bedaquiline,Linezolid,Median genome coverage,Percentage reads mapped,Quality,Database version
B,Mycobacterium tuberculosis,Lineage 2,Multi-drug resistance predicted (MDR-TB),rpoB_p.Ser450Leu (Resistant|High),katG_p.Ser315Thr (Resistant|High),pncA_p.Ser59Phe (Resistant|Uncertain),embA_c.-11C>A (Resistant|Uncertain),No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,rpsL_p.Lys43Arg (Resistant only in combination|High),No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,160,98.34,Pass QC,tbtamr_2022-12-02
